Andra AP-fonden’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Sell |
332,662
-348,938
| -51% | -$20.3M | 0.24% | 93 |
|
|
2025
Q4 | $36.8M | Sell |
681,600
-495,300
| -42% | -$23.8M | 0.45% | 48 |
|
|
2025
Q3 | $53.1M | Buy |
1,176,900
+463,991
| +65% | +$21.7M | 0.68% | 26 |
|
|
2025
Q2 | $33M | Buy |
712,909
+600,609
| +535% | +$29.5M | 0.46% | 67 |
|
|
2025
Q1 | $6.85M | Buy |
+112,300
| New | +$6.55M | 0.11% | 254 |
|
|
2024
Q2 | – | Sell |
-1,019,000
| Closed | -$55.3M | – | 421 |
|
|
2024
Q1 | $55.3M | Buy |
+1,019,000
| New | +$51.9M | 0.98% | 14 |
|
|
2023
Q3 | – | Sell |
-190,600
| Closed | -$12.2M | – | 304 |
|
|
2023
Q2 | $12.2M | Buy |
190,600
+52,500
| +38% | +$3.52M | 0.31% | 50 |
|
|
2023
Q1 | $9.57M | Buy |
138,100
+16,400
| +13% | +$1.16M | 0.25% | 132 |
|
|
2022
Q4 | $8.76M | Sell |
121,700
-50,700
| -29% | -$3.82M | 0.27% | 99 |
|
|
2022
Q3 | $12.3M | Sell |
172,400
-28,000
| -14% | -$2.03M | 0.4% | 22 |
|
|
2022
Q2 | $15.4M | Buy |
+200,400
| New | +$15.3M | 0.44% | 7 |
|
|
2021
Q4 | $11.7M | Sell |
187,400
-5,400
| -3% | -$317K | 0.24% | 157 |
|
|
2021
Q3 | $11.4M | Sell |
192,800
-17,100
| -8% | -$1.13M | 0.23% | 141 |
|
|
2021
Q2 | $14M | Buy |
209,900
+66,200
| +46% | +$4.32M | 0.29% | 65 |
|
|
2021
Q1 | $9.07M | Buy |
143,700
+23,100
| +19% | +$1.44M | 0.2% | 211 |
|
|
2020
Q4 | $7.48M | Sell |
120,600
-500
| -0.4% | -$30.7K | 0.17% | 312 |
|
|
2020
Q3 | $7.3M | Sell |
121,100
-13,500
| -10% | -$813K | 0.2% | 186 |
|
|
2020
Q2 | $7.91M | Sell |
134,600
-31,600
| -19% | -$1.89M | 0.23% | 81 |
|
|
2020
Q1 | $9.26M | Buy |
166,200
+4,600
| +3% | +$281K | 0.34% | 8 |
|
|
2019
Q4 | $10.4M | Sell |
161,600
-3,100
| -2% | -$178K | 0.3% | 5 |
|
|
2019
Q3 | $8.35M | Sell |
164,700
-45,500
| -22% | -$2.14M | 0.25% | 34 |
|
|
2019
Q2 | $9.53M | Buy |
210,200
+15,900
| +8% | +$741K | 0.27% | 13 |
|
|
2019
Q1 | $9.27M | Buy |
+194,300
| New | +$9.68M | 0.27% | 24 |
|
|
2018
Q3 | $13.8M | Sell |
221,800
-11,400
| -5% | -$677K | 0.36% | 9 |
|
|
2018
Q2 | $12.9M | Buy |
233,200
+80,400
| +53% | +$4.34M | 0.35% | 4 |
|
|
2018
Q1 | $9.66M | Sell |
152,800
-1,200
| -0.8% | -$77.2K | 0.25% | 47 |
|
|
2017
Q4 | $9.44M | Buy |
154,000
+56,500
| +58% | +$3.53M | 0.21% | 132 |
|
|
2017
Q3 | $6.21M | Buy |
97,500
+1,200
| +1% | +$70.1K | 0.15% | 183 |
|
|
2017
Q2 | $5.37M | Sell |
96,300
-7,700
| -7% | -$419K | 0.13% | 211 |
|
|
2017
Q1 | $5.66K | Hold |
104,000
| – | – | 0.13% | 200 |
|
|
2016
Q4 | $6.08M | Sell |
104,000
-181,900
| -64% | -$9.94M | 0.17% | 167 |
|
|
2016
Q3 | $15.4M | Buy |
285,900
+21,400
| +8% | +$1.37M | 0.41% | 51 |
|
|
2016
Q2 | $19.5M | Sell |
264,500
-3,800
| -1% | -$269K | 0.5% | 34 |
|
|
2016
Q1 | $17.1M | Sell |
268,300
-22,000
| -8% | -$1.39M | 0.45% | 45 |
|
|
2015
Q4 | $20M | Sell |
290,300
-14,000
| -5% | -$925K | 0.57% | 35 |
|
|
2015
Q3 | $18M | Buy |
304,300
+7,700
| +3% | +$488K | 0.53% | 36 |
|
|
2015
Q2 | $19.7M | Buy |
296,600
+30,000
| +11% | +$1.98M | 0.57% | 30 |
|
|
2015
Q1 | $17.2M | Sell |
266,600
-9,200
| -3% | -$576K | 0.49% | 40 |
|
|
2014
Q4 | $16.3M | Buy |
275,800
+4,000
| +1% | +$226K | 0.38% | 58 |
|
|
2014
Q3 | $13.9M | Sell |
271,800
-151,800
| -36% | -$7.58M | 0.33% | 79 |
|
|
2014
Q2 | $20.5M | Buy |
423,600
+135,200
| +47% | +$6.66M | 0.45% | 44 |
|
|
2014
Q1 | $15M | Buy |
288,400
+34,200
| +13% | +$1.82M | 0.35% | 68 |
|
|
2013
Q4 | $13.5M | Sell |
254,200
-21,600
| -8% | -$1.1M | 0.32% | 75 |
|
|
2013
Q3 | $12.8M | Sell |
275,800
-12,400
| -4% | -$544K | 0.33% | 64 |
|
|
2013
Q2 | $12.9M | Buy |
+288,200
| New | +$12.5M | 0.34% | 67 |
|
Other funds holding BMY
VCM
VPM
Andra AP-fonden's BMY Position: Q1 2026 in Review
Andra AP-fonden reduced its Bristol-Myers Squibb (BMY) stake by 51% in Q1 2026, selling an estimated $20.3M and leaving 332,662 shares worth $20.2M. The position accounts for 0.24% of the portfolio, ranked #93.
Andra AP-fonden first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $55.3M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Andra AP-fonden held 332,662 shares of Bristol-Myers Squibb worth $20.2M as of Q1 2026.
- Andra AP-fonden sold 348,938 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.3M.
- Bristol-Myers Squibb made up 0.24% of Andra AP-fonden's portfolio in Q1 2026, its #93 holding.
- Andra AP-fonden first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
- Andra AP-fonden's Bristol-Myers Squibb position peaked at $55.3M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.